AYTU BIOPHARMA, INC Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AYTU BIOPHARMA, INC stock issued during period, value, new issues for the quarter ending 2023-12-31 was $86.00K, a 92.15% decline year-over-year.
- AYTU BIOPHARMA, INC stock issued during period, value, new issues for the quarter ending 2023-03-31 was $1.39M, a 63.87% decline year-over-year.
- AYTU BIOPHARMA, INC stock issued during period, value, new issues for the quarter ending 2022-12-31 was $1.09M, a 74.86% decline year-over-year.
- AYTU BIOPHARMA, INC stock issued during period, value, new issues for the quarter ending 2022-09-30 was $3.56M, a 1220.00% increase year-over-year.
- AYTU BIOPHARMA, INC stock issued during period, value, new issues for fiscal 2025 was $3.77M.
- AYTU BIOPHARMA, INC stock issued during period, value, new issues for fiscal 2023 was $6.05M, a 31.62% decline from fiscal 2022.
- AYTU BIOPHARMA, INC stock issued during period, value, new issues for fiscal 2022 was $8.85M, a 78.76% decline from fiscal 2021.
- AYTU BIOPHARMA, INC stock issued during period, value, new issues for fiscal 2021 was $41.68M, a 25.25% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $3.77M 10-K · filed 2026-09-22 | |
| 2023-12-31 | $86.00K 10-Q · filed 2024-05-15 | |
| 2023-06-30 | $6.05M 10-K · filed 2024-09-26 | |
| 2023-03-31 | $1.39M 10-Q · filed 2024-05-15 | $3.25M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $1.09M 10-Q · filed 2024-05-15 | $5.71M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-09-30 | $3.56M 10-Q · filed 2024-05-15 | $8.97M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-06-30 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $8.85M 10-K · filed 2023-10-12 |
| 2022-03-31 | $3.86M 10-Q · filed 2023-05-11 | $20.67M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $4.36M 10-Q · filed 2023-05-11 | |
| 2021-09-30 | $270.00K 10-Q · filed 2023-05-11 | |
| 2021-06-30 | $12.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $41.68M 10-K · filed 2022-09-27 |
| 2020-12-31 | $28.32M 10-Q · filed 2021-05-17 | |
| 2020-06-30 | $33.28M 10-K · filed 2020-10-06 | |
| 2020-03-31 | $33.28M 10-Q · filed 2021-05-17 | |
| 2019-06-30 | $11.81M 10-K · filed 2020-10-06 | |
| 2018-12-31 | $11.81M 10-Q · filed 2020-05-15 | |
| 2018-06-30 | $9.17M 10-K · filed 2019-09-26 | |
| 2018-03-31 | $9.17M 10-Q · filed 2019-05-14 | |
| 2017-06-30 | $41.70K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $648.93K 10-K · filed 2017-08-31 |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $607.23K derived: sum of 4 quarters · filed 2017-08-31 |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | |
| 2016-09-30 | $607.23K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $200.00K 10-K · filed 2017-08-31 |
| 2014-11-30 | $15.00K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2015-04-15 | $17.70K 10-Q · filed 2015-04-15 |
| 2013-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $5.00K 10-K · filed 2014-11-26 |
| 2013-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-28 | $6.50K derived: sum of 4 quarters · filed 2014-07-10 |
| 2013-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-15 | $11.22K derived: sum of 4 quarters · filed 2014-07-10 |
| 2012-11-30 | $5.00K 10-Q · filed 2013-01-14 | $17.23K derived: sum of 4 quarters · filed 2014-07-10 |
| 2012-08-31 | $1.50K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-07-10 | $18.21K 10-Q · filed 2014-07-10 |
| 2012-05-31 | $4.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-06-26 | |
| 2012-02-29 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-12 | |
| 2011-11-30 | $5.99K 10-Q · filed 2011-12-23 | |
| 2011-08-31 | $43.50K 10-K · filed 2014-11-26 | |
| 2010-08-31 | $13.90K 10-K · filed 2014-11-26 | |
| 2009-08-31 | $16.10K 10-K · filed 2014-11-26 | |
| 2008-08-31 | $59.75K 10-K · filed 2014-11-26 | |
| 2006-08-31 | $50.00K 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |